Myasthenia Gravis (MG) is a chronic autoimmune neuromuscular disorder. It causes weakness in the skeletal muscles that control breathing and movement. The condition occurs when the immune system attacks the connection between nerves and muscles, specifically targeting acetylcholine receptors at the neuromuscular junction.
Goals of Treatment
- Improve muscle strength
- Reduce immune system attacks
- Control symptoms and prevent crises
- Enhance daily function and overall well-being
Treatment is highly individualized, depending on age, symptom severity, and overall health.
Main Treatment Options for Myasthenia Gravis
-
Acetylcholinesterase Inhibitors
These medications increase communication between nerves and muscles by preventing the breakdown of acetylcholine.- Drug of choice: Pyridostigmine (Mestinon)
- Improves symptoms like drooping eyelids and muscle fatigue
- Works within minutes and may be used long-term
-
Corticosteroids
Steroids reduce the immune system's attack on neuromuscular junctions.- Prednisone is most commonly used
- Effective in controlling moderate to severe symptoms
- Tapered slowly to avoid relapse
- Long-term use requires monitoring for side effects (diabetes, osteoporosis, etc.)
-
Immunosuppressants
These drugs suppress the immune system to prevent further damage.- Azathioprine
- Mycophenolate mofetil
- Cyclosporine
- Used when steroids alone aren't enough or to help reduce steroid dosage.
-
Intravenous Immunoglobulin (IVIG)
- Provides a temporary boost to the immune system
- Used during myasthenic crises or before surgery
- Usually given over 3–5 days via IV
-
Plasmapheresis (Plasma Exchange)
- Removes antibodies from the blood that attack the neuromuscular junction
- Offers rapid symptom relief during severe flares
- Effects are temporary but life-saving in emergencies
-
Thymectomy (Surgical Removal of Thymus)
The thymus gland plays a role in MG by producing abnormal antibodies. Thymectomy is often recommended for:- Patients with thymoma (tumor of the thymus)
- Generalized MG, especially in younger adults
- Studies show long-term symptom improvement even without tumors
- Minimally invasive techniques like VATS or robotic surgery are commonly used.
-
Monoclonal Antibody Therapy
These are newer treatments that target specific parts of the immune system.- Eculizumab: Approved for refractory MG (when other treatments fail)
- Rituximab: Often used in MuSK antibody-positive patients
- Highly effective in some severe or resistant cases
Lifestyle and Supportive Care
- Balanced rest and activity: Avoid fatigue
- Avoid overheating and infections: Can worsen symptoms
- Speech therapy: For patients with swallowing issues
- Respiratory support: During myasthenic crisis
- Mental health care: Anxiety and depression are common and manageable
Monitoring and Follow-Up
- Regular neurology checkups
- Monitor for side effects of immunosuppressants
- Adjust medications based on symptom changes
- Vaccinations should be discussed with your doctor
Prognosis and Quality of Life
- Most patients lead normal or near-normal lives
- Early diagnosis and a tailored treatment plan ensure better control
- New therapies continue to improve outcomes and reduce side effects
